🇺🇸 FDA
Pipeline program

Oral versus topical antibioitics

NMCSD.2018.0060.

Phase 2 small_molecule terminated

Quick answer

Oral versus topical antibioitics for Chronic Rhinosinusitis (Diagnosis) is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Chronic Rhinosinusitis (Diagnosis)
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials